Torrance G W, Zipursky A
Clin Perinatol. 1984 Jun;11(2):267-81.
While antepartum prophylaxis of Rh immunization is much more costly and the postpartum program is much more cost-effective, the question is whether the antepartum program is sufficiently cost-effective to warrant its use. How, in any given region, should the issue be tackled? This article addresses that question.
虽然产前预防Rh免疫的成本要高得多，而后产后方案的成本效益要高得多，但问题是产前方案是否具有足够的成本效益来保证其使用。在任何特定地区，应该如何解决这个问题？本文将探讨这个问题。
